INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 422m ago
House PTR22m ago
SEC 13F21m ago
Robinhood Chain21m ago

Results

73,241 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TE
Trumbull Katherine EEVP, Chief Marketing Officer
DPZDOMINOS PIZZA INC
Tax withholding
F$2,901
9 sh
Nov 2, 2026Nov 4, 2026
Page 142 of 1832
← PrevNext →
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

9
HW
Hu Da-WaiEVP & General Counsel
LYVLive Nation Entertainment, Inc.
Grant or award
A—
28.9K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
HD
Hirji DinazChief People Officer
FDSFACTSET RESEARCH SYSTEMS INC
Grant or award
A—
4,834 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$587K
4,988 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

9
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$540K
4,561 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

9
SB
Stiefel Justin BDirector, CEO & Treasurer
IPSTIP STRATEGY HOLDINGS, INC.
Option exercise
M—
1,458 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
MT
Moskoff Gregory TMD,Controller and CAO
FDSFACTSET RESEARCH SYSTEMS INC
Grant or award
A—
1,355 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
GD
Graham Tracy DDirector
SRCE1ST SOURCE CORP
Grant or award
A$14K
158 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
VJ
Vecchio JenniferGroup President and CMO
BURLBurlington Stores, Inc.
Open-market sale · 10b5-1 plan
SELL$119K
505 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
VJ
Vecchio JenniferGroup President and CMO
BURLBurlington Stores, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
618 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
PJ
Piazza Nicholas J.Senior VP & CPO
EMREMERSON ELECTRIC CO
Tax withholding
F$146K
875 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
BR
Burchianti RalphDirector
CBFVCB Financial Services, Inc.
Option exercise
M—Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,989 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
300 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
8,252 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
5,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,375 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.5K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
14.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
100.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$526K
24.7K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,250 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
379 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$204K
4,485 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Open-market sale · 10b5-1 plan
SELL$4,239
100 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$140K
3,052 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
4,977 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
17.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$526K
24.7K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
900 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
18.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
GL
George Jennifer LSEVP and COO
CBFVCB Financial Services, Inc.
Option exercise
M—Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,253
370 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$2,603
23 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence